Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL2020 in ischemic stroke
jRCT1080224042Phase 2Completed
- Sponsor
- Life Science Institute
- Start
- Sep 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke and brain infarction comparing CL2020 with Placebo (2 arms). Primary endpoint: Safety outcomes. Started Sep 2018; status: completed.
02
Drugs
CL2020
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on jRCT1080224042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224042.